Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T99799
|
||||
Former ID |
TTDS00143
|
||||
Target Name |
Cholinesterase
|
||||
Synonyms |
Acylcholine acylhydrolase; BuChE; Butyrylcholine esterase; Butyrylcholinesterase; Choline esterase II; Pseudocholinesterase
|
||||
Target Type |
Successful
|
||||
Disease | Alzheimer disease [ICD9: 331; ICD10: G30] | ||||
Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10: F01-F07, F04, F05, R41.3] | |||||
Neurotoxicity drug-induced [ICD10: T36-T50] | |||||
Poison intoxication [ICD10: T36-T50] | |||||
Pain [ICD9: 338, 356.0, 356.8,780; ICD10: G64, G90.0, R52, G89] | |||||
Spasms; Pain [ICD9: 338,780; ICD10: R52, G89] | |||||
Toxicity [ICD10: T36-T50, T51-T65] | |||||
Function |
Esterasewith broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters.
|
||||
BioChemical Class |
Carboxylic ester hydrolase
|
||||
Target Validation |
T99799
|
||||
EC Number |
EC 3.1.1.8
|
||||
Drugs and Mode of Action | |||||
Drug(s) | Hexafluronium bromide | Drug Info | Approved | Spasms; Pain | [1], [2] |
MEPTAZINOL | Drug Info | Approved | Pain | [2] | |
(-)-Phenserine | Drug Info | Phase 3 | Alzheimer disease | [3] | |
JES-9501 | Drug Info | Phase 1 | Alzheimer disease | [4] | |
Plasma derived human butyrylcholinesterase | Drug Info | Phase 1 | Neurotoxicity drug-induced | [5] | |
Protexia | Drug Info | Phase 1 | Alzheimer disease | [6] | |
Inhibitor | (+/-)-huprineY hydrochloride | Drug Info | [7] | ||
(-)-DEBROMOFLUSTRAMINE B | Drug Info | [8] | |||
(-)-Phenethylcymserine | Drug Info | [9] | |||
(-)-Phenserine | Drug Info | [9] | |||
(-)-Tolserine | Drug Info | [9] | |||
(1'H-Phenothiazin-1'-yl)(piperidin-1-yl)methanone | Drug Info | [10] | |||
(10H-phenothiazin-10-yl)(m-tolyl)methanone | Drug Info | [11] | |||
(10H-phenothiazin-10-yl)(o-tolyl)methanone | Drug Info | [11] | |||
(10H-phenothiazin-10-yl)(p-tolyl)methanone | Drug Info | [11] | |||
(10H-phenothiazin-10-yl)(phenyl)methanone | Drug Info | [11] | |||
(1R)-MENTHYL HEXYL PHOSPHONATE GROUP | Drug Info | [12] | |||
(1S)-MENTHYL HEXYL PHOSPHONATE GROUP | Drug Info | [12] | |||
(24S)-ethylcholesta-7,9(11),22(E)-triene-3b-ol | Drug Info | [13] | |||
(3-bromophenyl)(10H-phenothiazin-10-yl)methanone | Drug Info | [11] | |||
(4-bromophenyl)(10H-phenothiazin-10-yl)methanone | Drug Info | [11] | |||
(4-nitrophenyl)(10H-phenothiazin-10-yl)methanone | Drug Info | [11] | |||
(RS)-tacrine(10)-hupyridone | Drug Info | [14] | |||
1,10-bis(pyridinium)-decane dibromide | Drug Info | [15] | |||
1,11-bis(pyridinium)-undecane dibromide | Drug Info | [15] | |||
1,2-bis(2,3-fluorophenyl)ethane-1,2-dione | Drug Info | [16] | |||
1,2-di(10H-phenothiazin-10-yl)ethane-1,2-dione | Drug Info | [11] | |||
1,2-Di(berberine-9-O-yl)ethane dibromide | Drug Info | [17] | |||
1,2-indanedione | Drug Info | [18] | |||
1,2-NAPHTHOQUINONE | Drug Info | [18] | |||
1,3-Di(berberine-9-O-yl)ethane dibromide | Drug Info | [17] | |||
1,4-Di(berberine-9-O-yl)ethane dibromide | Drug Info | [17] | |||
1,9-bis(pyridinium)-nonane dibromide | Drug Info | [15] | |||
1-(10H-phenothiazin-10-yl)-2-phenylbutan-1-one | Drug Info | [11] | |||
1-(10H-phenothiazin-10-yl)-2-phenylethanone | Drug Info | [11] | |||
1-(10H-phenothiazin-10-yl)-2-phenylpropan-1-one | Drug Info | [11] | |||
1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one | Drug Info | [11] | |||
1-(10H-phenothiazin-10-yl)-3-phenylpropan-1-one | Drug Info | [11] | |||
1-(10H-phenothiazin-10-yl)-4-phenylbutan-1-one | Drug Info | [11] | |||
1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione | Drug Info | [19] | |||
1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide | Drug Info | [9] | |||
2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine | Drug Info | [20] | |||
2-(N-Morpholino)-Ethanesulfonic Acid | Drug Info | [21] | |||
2-biphenyl-4-yl-1-phenothiazin-10-yl-ethanone | Drug Info | [11] | |||
2-methoxyphenyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
2-Methyl-beta-carboline-2-ium iodide | Drug Info | [23] | |||
2-Propyl-beta-carboline-2-ium iodide | Drug Info | [23] | |||
24-ethyl-cholest-7-ene-3,5,6-triol | Drug Info | [13] | |||
24-ethylcholest-6-ene-3,5-diol | Drug Info | [13] | |||
3,4,5,6-Tetrachloro-[1,2]benzoquinone | Drug Info | [24] | |||
3-(2-Diethylamino-acetamino)-rutaecarpine | Drug Info | [25] | |||
3-(2-Diethylamino-propionamino)-rutaecarpine | Drug Info | [25] | |||
3-(2-N-Piperidyl-propionamino)-rutaecarpine | Drug Info | [25] | |||
3-(2-N-Pyrrolyl-acetamino)-rutaecarpine | Drug Info | [25] | |||
3-(2-N-Pyrrolyl-propionamino)-rutaecarpine | Drug Info | [25] | |||
3-(dimethylamino)phenyl phenylcarbamate | Drug Info | [9] | |||
3-chlorophenyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
3-isopr-sal-cyclosal-d4TMP | Drug Info | [26] | |||
3-methoxyphenyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
3-phenyl-cyclosal-d4TMP | Drug Info | [26] | |||
3-sal-cyclosal-d4TMP | Drug Info | [26] | |||
3-[10-(benzylmethylamino)decyloxy]xanthen-9-one | Drug Info | [27] | |||
3-[11-(benzylmethylamino)undecyloxy]xanthen-9-one | Drug Info | [27] | |||
3-[12-(benzylmethylamino)dodecyloxy]xanthen-9-one | Drug Info | [27] | |||
3-[3-(benzylmethylamino)propoxy]xanthen-9-one | Drug Info | [27] | |||
3-[4-(benzylmethylamino)butoxy]xanthen-9-one | Drug Info | [27] | |||
3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one | Drug Info | [27] | |||
3-[6-(benzylmethylamino)hexyloxy]xanthen-9-one | Drug Info | [27] | |||
3-[7-(benzylmethylamino)-heptyloxy]xanthen-9-one | Drug Info | [27] | |||
3-[8-(benzylmethylamino)octyloxy]xanthen-9-one | Drug Info | [27] | |||
3-[9-(benzylmethylamino)nonyloxy]xanthen-9-one | Drug Info | [27] | |||
4-chlorophenyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
4-ISOPROPYLPHENSERINE | Drug Info | [28] | |||
4-methoxyphenyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
4-[4-(benzyloxy)piperidino]butyl benzoate | Drug Info | [29] | |||
4-[4-(benzyloxy)piperidino]butyl-3-chlorobenzoate | Drug Info | [29] | |||
4-[4-(benzyloxy)piperidino]butyl-3-fluorobenzoate | Drug Info | [29] | |||
4-[4-(benzyloxy)piperidino]butyl-4-chlorobenzoate | Drug Info | [29] | |||
4-[4-(benzyloxy)piperidino]butyl-4-fluorobenzoate | Drug Info | [29] | |||
4-[4-(benzyloxy)piperidino]butyl-4-nitrobenzoate | Drug Info | [29] | |||
5,6-dinitroacenaphthoquinone | Drug Info | [18] | |||
5-methyl-cyclosal-d4TMP | Drug Info | [26] | |||
6-chlorotacrine hydrochloride | Drug Info | [30] | |||
6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium | Drug Info | [31] | |||
6-hydroxy-1,2-dimethyl-9H-beta-carbolin-2-ium | Drug Info | [31] | |||
6-hydroxy-2-methyl-9H-beta-carbolin-2-ium | Drug Info | [31] | |||
6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium | Drug Info | [31] | |||
6-methoxy-1,9-dimethyl-9H-pyrido[3,4-b]indole | Drug Info | [31] | |||
6-methoxy-2-methyl-9H-beta-carbolin-2-ium | Drug Info | [31] | |||
7-Oxo-7H-dibenzo[de,g]quinoline | Drug Info | [32] | |||
9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE | Drug Info | [12] | |||
9-Ethyl-2-methyl-beta-carboline-2-ium iodide | Drug Info | [23] | |||
9-N-Phenylmethylamino-Tacrine | Drug Info | [21] | |||
9-O-[2-(Phenylol-1-yloxy)ethyl]berberine bromide | Drug Info | [33] | |||
9-O-[2-(Phenylol-1-yloxy)hexyl]berberine bromide | Drug Info | [33] | |||
9-O-[3-(2-Pyridinoxyl)butyl]-berberine bromide | Drug Info | [17] | |||
9-O-[3-(4-Bromo-phenoxyl)butyl]-berberine bromide | Drug Info | [17] | |||
9-O-[3-(4-Nitro-phenoxyl)butyl]-berberine bromide | Drug Info | [17] | |||
9-O-[3-(Phenylamino)propyl]-berberine bromide | Drug Info | [17] | |||
9-O-[3-(Phenylol-1-yloxy)propyl]berberine bromide | Drug Info | [33] | |||
9-O-[4-(Phenylol-1-yloxy)butyl]berberine bromide | Drug Info | [33] | |||
9-O-[5-(Phenylol-1-yloxy)pentyl]berberine bromide | Drug Info | [33] | |||
9-[5-(beta-Carboline-9-yl)pentyl]-beta-carboline | Drug Info | [23] | |||
9-[9-(beta-Carboline-9-yl)nonyl]-beta-carboline | Drug Info | [23] | |||
ACENAPHTHOQUINONE | Drug Info | [18] | |||
Alpha-D-Mannose | Drug Info | [21] | |||
Anthracen-10-yl(10H-phenothiazin-10-yl)methanone | Drug Info | [11] | |||
AS-1397 | Drug Info | [34] | |||
BChE inhibitors | Drug Info | [35] | |||
BENZOQUINONE | Drug Info | [24] | |||
Beta-D-Mannose | Drug Info | [21] | |||
Bis-7-tacrine | Drug Info | [36] | |||
Bis-cyclosal-d4TMP | Drug Info | [26] | |||
Butanoic Acid | Drug Info | [21] | |||
Butyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Butyrylthiocholine | Drug Info | [37] | |||
CAPROCTAMINE | Drug Info | [38] | |||
CHF-2819 | Drug Info | [39] | |||
CHLORANIL | Drug Info | [24] | |||
Cyclopentyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Cyclosal-d4TMP | Drug Info | [26] | |||
Cymserine | Drug Info | [40] | |||
DEMETHYLDEBROMOFLUSTRAMINE B | Drug Info | [8] | |||
Diethylphosphono Group | Drug Info | [21] | |||
DODECANESULFONATE ION | Drug Info | [12] | |||
Ethyl Dihydrogen Phosphate | Drug Info | [21] | |||
ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE | Drug Info | [12] | |||
Fucose | Drug Info | [21] | |||
HALOXYSTEROL A | Drug Info | [13] | |||
HALOXYSTEROL B | Drug Info | [13] | |||
Haloxysterol C | Drug Info | [13] | |||
Haloxysterol D | Drug Info | [13] | |||
HEPTYPHYSOSTIGMINE | Drug Info | [41] | |||
Hexafluronium bromide | Drug Info | [42] | |||
Huprine X | Drug Info | [43] | |||
Huprine-Tacrine Heterodimer | Drug Info | [44] | |||
Iso-OMPA | Drug Info | [45] | |||
Isopropyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Isosorbide-2-(benzylcarbamate)-5-benzoate | Drug Info | [45] | |||
Isosorbide-2-(benzylcarbamate)-5-mononitrate | Drug Info | [45] | |||
Isosorbide-2-(butylcarbamate)-5-benzoate | Drug Info | [45] | |||
Isosorbide-2-(butylcarbamate)-5-mononitrate | Drug Info | [45] | |||
Isosorbide-2-(cyclohexylcarbamate)-5-mononitrate | Drug Info | [45] | |||
Isosorbide-2-(ethylcarbamate)-5-mononitrate | Drug Info | [45] | |||
Isosorbide-2-(methylcarbamate)-5-benzoate | Drug Info | [45] | |||
Isosorbide-2-(methylcarbamate)-5-mononitrate | Drug Info | [45] | |||
Isosorbide-2-(propylcarbamate)-5-mononitrate | Drug Info | [45] | |||
Isosorbide-2-benzyl carbamate | Drug Info | [46] | |||
Isosorbide-2-benzylcarbamate-5-(o-toluate) | Drug Info | [46] | |||
Isosorbide-2-benzylcarbamate-5-acetate | Drug Info | [45] | |||
Isosorbide-2-benzylcarbamate-5-cyclopentanoate | Drug Info | [45] | |||
Isosorbide-2-benzylcarbamate-5-cyclopropanoate | Drug Info | [45] | |||
Isosorbide-2-benzylcarbamate-5-isonicotinate | Drug Info | [45] | |||
Isosorbide-2-benzylcarbamate-5-nicotinate | Drug Info | [45] | |||
Isosorbide-2-benzylcarbamate-5-pentanoate | Drug Info | [45] | |||
Isosorbide-2-benzylcarbamate-5-propionate | Drug Info | [45] | |||
Isosorbide-2-benzylcarbamate-5-triflate | Drug Info | [45] | |||
Isosorbide-di-(benzylcarbamate) | Drug Info | [47] | |||
Isosorbide-di-(butylcarbamate) | Drug Info | [47] | |||
Isosorbide-di-(ethylcarbamate) | Drug Info | [47] | |||
Isosorbide-di-(propylcarbamate) | Drug Info | [47] | |||
LAWSARITOL | Drug Info | [13] | |||
LIPOCRINE | Drug Info | [48] | |||
M-tolyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
MEMOQUIN | Drug Info | [48] | |||
MEPTAZINOL | Drug Info | [49] | |||
Methyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Methyl Phosphinic Acid | Drug Info | [21] | |||
MF-8623 | Drug Info | [40] | |||
Monoisopropyl Ester Phosphonic Acid Group | Drug Info | [21] | |||
Morpholino(1'H-phenothiazin-1'-yl)methanone | Drug Info | [10] | |||
N,N'-(1',10'-decylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',11'-undecydene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',12'-dodecydene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',2'-ethylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',3'-propylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',4'-butylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',5'-pentylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',6-hexylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',7'-heptylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',8'-octylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP | Drug Info | [49] | |||
N,N-Diethyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N,N-Diisopropyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N,N-Dimethyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N,N-Dipropyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-(Adamant-1-yl)-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-Benzyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-benzyl-2-thiomorpholinopyrimidin-4-amine | Drug Info | [36] | |||
N-Cyclobutyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-Cyclohexyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-Cyclopentyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-Isopropyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-Methyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-n-heptyl-7-methoxytacrine hydrochloride | Drug Info | [50] | |||
N-n-hexyl-7-methoxytacrine hydrochloride | Drug Info | [50] | |||
N-n-nonyl-7-methoxytacrine hydrochloride | Drug Info | [50] | |||
N-n-octyl-7-methoxytacrine hydrochloride | Drug Info | [50] | |||
N-n-pentyl-7-methoxytacrine hydrochloride | Drug Info | [50] | |||
N-Neopentyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-o-Tolyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-p-Tolyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine | Drug Info | [36] | |||
N-Phenyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
N-tert-Butyl-1'H-phenothiazine-1'-carboxamide | Drug Info | [10] | |||
Naphthalen-1-yl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Naphthalen-1-yl(10H-phenothiazin-10-yl)methanone | Drug Info | [11] | |||
Naphthalen-2-yl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Naphthalen-2-yl(10H-phenothiazin-10-yl)methanone | Drug Info | [11] | |||
NOSTOCARBOLINE | Drug Info | [51] | |||
NP-0336 | Drug Info | [35] | |||
NSC-23180 | Drug Info | [18] | |||
O-tolyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
P-tolyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Phenanthrene-9,10-dione | Drug Info | [18] | |||
Phenyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
Tert-butyl 10H-phenothiazine-10-carboxylate | Drug Info | [22] | |||
TOLSERINE | Drug Info | [41] | |||
VAGANINE D | Drug Info | [52] | |||
XANTHOSTIGMINE | Drug Info | [53] | |||
Modulator | JES-9501 | Drug Info | [4] | ||
Non-PEGylated butyrylcholinesterase | Drug Info | [35] | |||
Plasma derived human butyrylcholinesterase | Drug Info | [54] | |||
Protexia | Drug Info | [55] | |||
Recombinant human butyrylcholinesterase | Drug Info | [35] | |||
Pathways | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
WikiPathways | Irinotecan Pathway | ||||
References | |||||
REF 1 | Pharmacology, clinical uses, and adverse effects of ceruletide, a cholecystokinetic agent. Pharmacotherapy. 1982 Jul-Aug;2(4):223-34. | ||||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
REF 3 | Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease. PLoS One. 2013;8(1):e54887. | ||||
REF 4 | Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice. Eur J Pharmacol. 2001 Feb 16;413(2-3):221-5. | ||||
REF 5 | ClinicalTrials.gov (NCT00333528) A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly. U.S. National Institutes of Health. | ||||
REF 6 | ClinicalTrials.gov (NCT00744146) First Time in Human Study of Protexia. U.S. National Institutes of Health. | ||||
REF 7 | J Med Chem. 2006 Nov 16;49(23):6833-40.Binding of 13-amidohuprines to acetylcholinesterase: exploring the ligand-induced conformational change of the gly117-gly118 peptide bond in the oxyanion hole. | ||||
REF 8 | J Med Chem. 2008 Sep 11;51(17):5271-84. Epub 2008 Aug 8.Synthesis and biological evaluation of (-)- and (+)-debromoflustramine B and its analogues as selective butyrylcholinesterase inhibitors. | ||||
REF 9 | Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg Med Chem. 2010 Jul 1;18(13):4687-93. doi: 10.1016/j.bmc.2010.05.022. Epub 2010 May 12. | ||||
REF 10 | Bioorg Med Chem. 2010 Mar 15;18(6):2232-44. Epub 2010 Feb 4.Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. | ||||
REF 11 | Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. Epub 2007 Jul 6.Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. | ||||
REF 12 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | ||||
REF 13 | Bioorg Med Chem Lett. 2006 Feb;16(3):573-80. Epub 2005 Nov 7.Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum. | ||||
REF 14 | J Med Chem. 2008 Jun 12;51(11):3154-70. Epub 2008 May 15.Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors. | ||||
REF 15 | Bioorg Med Chem Lett. 2010 Mar 1;20(5):1763-6. Epub 2010 Jan 20.Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initialstudy for Myasthenia gravis implications. | ||||
REF 16 | Bioorg Med Chem. 2007 Jun 1;15(11):3801-17. Epub 2007 Mar 12.Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils. | ||||
REF 17 | Bioorg Med Chem. 2010 Jun 15;18(12):4475-84. Epub 2010 Apr 27.Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase. | ||||
REF 18 | J Med Chem. 2007 Nov 15;50(23):5727-34. Epub 2007 Oct 17.Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1. | ||||
REF 19 | J Med Chem. 2007 Apr 19;50(8):1876-85. Epub 2007 Mar 23.Selective inhibition of carboxylesterases by isatins, indole-2,3-diones. | ||||
REF 20 | J Med Chem. 2006 Sep 7;49(18):5411-3.Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase. | ||||
REF 21 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | ||||
REF 22 | J Med Chem. 2008 Jul 24;51(14):4200-12. Epub 2008 Jun 21.Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. | ||||
REF 23 | J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents. | ||||
REF 24 | J Med Chem. 2005 Apr 21;48(8):2906-15.Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. | ||||
REF 25 | Eur J Med Chem. 2010 Apr;45(4):1415-23. Epub 2010 Jan 4.Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors. | ||||
REF 26 | J Med Chem. 2007 Mar 22;50(6):1335-46. Epub 2007 Mar 1.Bis-cycloSal-d4T-monophosphates: drugs that deliver two molecules of bioactive nucleotides. | ||||
REF 27 | Bioorg Med Chem. 2007 Jan 1;15(1):575-85. Epub 2006 Sep 27.Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones. | ||||
REF 28 | Bioorg Med Chem Lett. 2010 Mar 1;20(5):1718-20. Epub 2010 Jan 20.Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors. | ||||
REF 29 | Bioorg Med Chem. 2007 Oct 15;15(20):6596-607. Epub 2007 Jul 25.Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. | ||||
REF 30 | J Med Chem. 2009 Sep 10;52(17):5365-79.Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds. | ||||
REF 31 | Bioorg Med Chem Lett. 2006 Nov 15;16(22):5840-3. Epub 2006 Sep 1.6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors. | ||||
REF 32 | Eur J Med Chem. 2009 Jun;44(6):2523-32. Epub 2009 Jan 31.Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase. | ||||
REF 33 | Bioorg Med Chem. 2010 Feb;18(3):1244-51. Epub 2009 Dec 16.Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. | ||||
REF 34 | J Med Chem. 2006 Dec 14;49(25):7540-4.Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. | ||||
REF 35 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2471). | ||||
REF 36 | Bioorg Med Chem Lett. 2010 Jun 15;20(12):3606-9. Epub 2010 Apr 28.Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors. | ||||
REF 37 | DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-4. Nucleic Acids Res. 2011 January | ||||
REF 38 | J Med Chem. 2008 Nov 27;51(22):7308-12.Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer. | ||||
REF 39 | J Med Chem. 2005 Feb 24;48(4):986-94.Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. | ||||
REF 40 | A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin. 2001;17(3):159-65. | ||||
REF 41 | J Med Chem. 2006 Apr 6;49(7):2174-85.Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine. | ||||
REF 42 | Synergistic effect of acidosis and succinylcholine-induced hyperkalemia in spinal cord transected rats. Acta Anaesthesiol Scand. 1984 Feb;28(1):87-90. | ||||
REF 43 | J Med Chem. 2006 Jun 1;49(11):3421-5.Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites. | ||||
REF 44 | J Med Chem. 2005 Mar 24;48(6):1701-4.Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors. | ||||
REF 45 | J Med Chem. 2008 Oct 23;51(20):6400-9. Epub 2008 Sep 26.Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. | ||||
REF 46 | J Med Chem. 2010 Feb 11;53(3):1190-9.Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor. | ||||
REF 47 | Bioorg Med Chem. 2010 Feb;18(3):1045-53. Epub 2010 Jan 6.Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability. | ||||
REF 48 | J Med Chem. 2009 Dec 10;52(23):7883-6.Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks. | ||||
REF 49 | J Med Chem. 2008 Apr 10;51(7):2027-36. Epub 2008 Mar 12.Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation. | ||||
REF 50 | Bioorg Med Chem Lett. 2010 Oct 15;20(20):6093-5. Epub 2010 Aug 16.Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease. | ||||
REF 51 | J Nat Prod. 2005 Dec;68(12):1793-5.Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A. | ||||
REF 52 | J Nat Prod. 2001 Jun;64(6):842-4.Steroidal alkaloids from the leaves of Sarcococca coriacea of Nepalese origin. | ||||
REF 53 | J Med Chem. 1998 Oct 8;41(21):3976-86.Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives. | ||||
REF 54 | Acetylcholinesterase-Fc Fusion Protein (AChE-Fc): A Novel Potential Organophosphate Bioscavenger with Extended Plasma Half-Life. Bioconjug Chem. 2015 Aug 19;26(8):1753-8. | ||||
REF 55 | In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. Chem Biol Interact. 2005 Dec 15;157-158:363-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.